Cargando…

Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases

The development of brain metastases (BMs) in breast cancer (BC) patients remains a challenging complication. Current clinical practice guidelines recommend local treatment of BMs without changing systemic therapy (CST) in patients with stable extracranial disease. We retrospectively investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhalabi, Omar, Soomro, Zaid, Sun, Ryan, Hasanov, Elshad, Albittar, Aya, Tripathy, Debu, Valero, Vicente, Ibrahim, Nuhad K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979865/ https://www.ncbi.nlm.nih.gov/pubmed/33742001 http://dx.doi.org/10.1038/s41523-021-00235-7

Ejemplares similares

Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer
por: Garber, Haven R., et al.
Publicado: (2022)

Effects of tamoxifen on urinary incontinence: Case report and review of literature
por: Hasanov, Elshad, et al.
Publicado: (2017)

Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer
por: Askoxylakis, Vasileios, et al.
Publicado: (2019)

Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysis
por: Moss, Nelson S., et al.
Publicado: (2023)

The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence
por: Rabbie, Roy, et al.
Publicado: (2020)

Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype
por: Bashour, Sami I., et al.
Publicado: (2020)

Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan
por: Alder, Laura, et al.
Publicado: (2023)

Racial Disparities in MiT Family Translocation Renal Cell Carcinoma
por: Lu, Xiaofan, et al.
Publicado: (2023)

Addressing disparities in delivery of cancer care for patients with melanoma brain metastases—Not just a simple case of rurality
por: Riggs, Joseph, et al.
Publicado: (2023)

Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients
por: Bohlok, Ali, et al.
Publicado: (2020)

Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer
por: Walsh, Naomi, et al.
Publicado: (2020)

Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data
por: Lin, Nancy U., et al.
Publicado: (2023)

Relapsing acute myeloid leukemia presenting as hypopyon uveitis
por: Hegde, Sapna P, et al.
Publicado: (2011)

The Impact of Treatment for Smoking on Breast Cancer Patients’ Survival
por: Singareeka Raghavendra, Akshara, et al.
Publicado: (2022)

HER2 status and breast cancer therapy: recent advances
por: Tripathy, Debu
Publicado: (2009)

Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer
por: Singareeka Raghavendra, Akshara, et al.
Publicado: (2021)

The BMC Medicine breast cancer collection: an illustration of contemporary research and clinical care
por: Tripathy, Debu
Publicado: (2015)

A reminder of extinction reduces relapse in an animal model of voluntary behavior
por: Nieto, Javier, et al.
Publicado: (2017)

Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment
por: Hu, Mimi I., et al.
Publicado: (2013)

Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study
por: Lin, Nancy U., et al.
Publicado: (2021)

A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy
por: Spurr, Liam F., et al.
Publicado: (2022)

Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients
por: Lee, Seung-Shin, et al.
Publicado: (2016)

Validity of urges to smoke measures in predicting smoking relapse during treatment in primary care
por: Kotz, Daniel, et al.
Publicado: (2021)

Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma
por: Kaulen, Leon D, et al.
Publicado: (2022)

Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
por: Jerusalem, Guy, et al.
Publicado: (2022)

Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer
por: Ibrahim, Nuhad K.
Publicado: (2021)

A review of Central Nervous System Metastases: Diagnosis and Treatment, First Edition, 2020
por: Zuccato, Jeffrey A, et al.
Publicado: (2020)

Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission
por: Patel, Arisha, et al.
Publicado: (2021)

Ixabepilone development across the breast cancer continuum: a paradigm shift
por: Ibrahim, Nuhad K
Publicado: (2010)

Clustered repetitive transcranial magnetic stimulation for the prevention of depressive relapse/recurrence: a randomized controlled trial
por: Wang, Hua-Ning, et al.
Publicado: (2017)

Pathophysiological Role of TLR4 in Chronic Relapsing Itch Induced by Subcutaneous Capsaicin Injection in Neonatal Rats
por: Kim, Hee Joo, et al.
Publicado: (2022)

Aerobic and resistance exercise improves Reynolds risk score in overweight or obese breast cancer survivors
por: Lee, Kyuwan, et al.
Publicado: (2020)

Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1
por: Garderet, Laurent, et al.
Publicado: (2018)

Effects of Cohort Selection on the Results of Cost-Effectiveness Analysis of Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis
por: Becker III, Russell V., et al.
Publicado: (2011)

Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas
por: Alhalabi, Omar, et al.
Publicado: (2023)

Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature
por: Abdayem, Pamela, et al.
Publicado: (2014)

Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy
por: Weiss, Anna, et al.
Publicado: (2018)

Irritable bowel syndrome-like symptoms associated with endoscopic activity predict ulcerative colitis relapse in patients with clinical remission
por: Fukuba, Nobuhiko, et al.
Publicado: (2017)

Prognostic Factors in Patients with Metastatic Breast Cancer with Bone‐Only Metastases
por: Parkes, Amanda, et al.
Publicado: (2018)

Benign Metastasizing Leiomyomatosis to the Skin and Lungs, Intravenous Leiomyomatosis, and Leiomyomatosis Peritonealis Disseminata: A Series of Five Cases
por: Boavida Ferreira, João, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gguu9a8fshktbn4btld8l5vdfb